Viatris closes divestitures of OTC business
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
Subscribe To Our Newsletter & Stay Updated